[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kuwert et al., 1998 - Google Patents

Diagnosis of recurrent glioma with SPECT and iodine-123-α-methyl tyrosine

Kuwert et al., 1998

View PDF @Free from Publisher
Document ID
5165113219003392477
Author
Kuwert T
Woesler B
Morgenroth C
Lerch H
Schäfers M
Palkovic S
Matheja P
Brandau W
Wassmann H
Schober O
Publication year
Publication venue
Journal of Nuclear Medicine

External Links

Snippet

48129 Münster, Germany. to 17 mo after SPECT in seven cases, and by clinical course and histopathology in the remaining subject. Results: Patients with recurrence had significantly higher ratios of IMT uptake in the tumor area to that in a background region than …
Continue reading at jnm.snmjournals.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody or an immunoglobulin, or a fragment thereof, e.g. a camelised human single domain antibody, or the Fc fragment of an antibody
    • A61K51/1003—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody or an immunoglobulin, or a fragment thereof, e.g. a camelised human single domain antibody, or the Fc fragment of an antibody not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/0474—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0476—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/50—Clinical applications
    • A61B6/507—Clinical applications involving determination of haemodynamic parameters, e.g. perfusion CT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/02—Devices for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computerised tomographs
    • A61B6/037—Emission tomography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/02—Devices for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computerised tomographs
    • A61B6/032—Transmission computed tomography [CT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/48—Diagnostic techniques
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/42—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for detecting radiation specially adapted for radiation diagnosis
    • A61B6/4208—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector
    • A61B6/4258—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector for detecting non x-ray radiation, e.g. gamma radiation

Similar Documents

Publication Publication Date Title
Kuwert et al. Diagnosis of recurrent glioma with SPECT and iodine-123-α-methyl tyrosine
Delker et al. Dosimetry for 177 Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer
Hoh et al. Positron emission tomography in urological oncology
Bockisch et al. Hybrid imaging by SPECT/CT and PET/CT: proven outcomes in cancer imaging
Hohberg et al. Lacrimal glands may represent organs at risk for radionuclide therapy of prostate cancer with [177 Lu] DKFZ-PSMA-617
Dimopoulos et al. International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
Oriuchi et al. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities
JP2017500537A (en) Method of using SPECT / CT analysis to determine cancer stage
Pacilio et al. Improving the dose–myelotoxicity correlation in radiometabolic therapy of bone metastases with 153 Sm-EDTMP
Piccardo et al. Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [18F] FDG: version 1.0
Talbot et al. [18F]-FDG positron imaging in clinical management of lymphoma patients
O’Connor et al. Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer
Feng et al. Current status and future perspective on molecular imaging and treatment of neuroblastoma
Yamamoto et al. 99mTc-MIBI and 201Tl SPET in the detection of recurrent brain tumours after radiation therapy
Zamani-Siahkali et al. SPECT/CT, PET/CT, and PET/MRI for response assessment of bone metastases
EP2477661B1 (en) Selective detection of bone metastases in renal clear cell carcinoma
Alexiou et al. Correlation of glioma proliferation assessed by flow cytometry with 99mTc-Tetrofosmin SPECT uptake
Brandau et al. Diagnosis of Recurrent Glioma with SPECT and Iodine-123-a-Methyl Tyrosine
Franc et al. Preclinical SPECT and SPECT-CT in oncology
Nakaigawa et al. Evaluation of PET/CT imaging with [89Zr] Zr-DFO-girentuximab: a phase 1 clinical study in Japanese patients with renal cell carcinoma (Zirdac-JP)
Adamietz et al. Improvement of radiation treatment planning in squamous-cell head and neck cancer by immuno-SPECT
Padovano et al. Hybrid imaging for breast malignancies
RU2726601C1 (en) Diagnostic technique for surgical thyroid diseases using dynamic double-indicator scintigraphy
Freudenberg et al. 124I positron emission tomographic dosimetry and positron emission tomography/computed tomography imaging in differentiated thyroid cancer
Basu et al. PET and PET/CT in the management of thyroid cancer